Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 775 of 2529 entries
View as:

A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00457626 Org: User:
Start: 04/09/07 End: 05/25/09 Due: 05/25/10

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Phase: N/A Priority: Normal
NCT ID: NCT01365455 Org: User:
Start: 06/30/11 End: 04/30/13 Due: 04/30/14

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Phase: N/A Priority: Normal
NCT ID: NCT05900141 Org: User:
Start: 09/29/23 End: 08/24/28 Due: 08/24/29

XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United States

Phase: N/A Priority: Normal
NCT ID: NCT05157087 Org: User:
Start: 03/01/20 End: 12/01/20 Due: 12/01/21

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Phase: N/A Priority: Normal
NCT ID: NCT01385592 Org: User:
Start: 11/30/11 End: 09/30/12 Due: 09/30/13

Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT06737419 Org: User:
Start: 06/09/21 End: 02/05/24 Due: 02/05/25

Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program

Phase: N/A Priority: Normal
NCT ID: NCT00956293 Org: User:
Start: 07/31/09 End: 03/31/13 Due: 03/31/14

Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01193101 Org: User:
Start: 08/31/10 End: 04/30/11 Due: 04/30/12

A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod

Phase: N/A Priority: Normal
NCT ID: NCT03257358 Org: User:
Start: 09/19/17 End: 06/28/19 Due: 06/28/20

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT06824103 Org: User:
Start: 11/21/25 End: 01/11/32 Due: 01/11/33

Effectiveness of Early Intervention in Transfusion Independent Aplastic Anemia: a Retrospective Medical Claims Database Study

Phase: N/A Priority: Normal
NCT ID: NCT06669221 Org: User:
Start: 05/05/22 End: 11/03/23 Due: 11/03/24

This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.

Phase: N/A Priority: Normal
NCT ID: NCT03968419 Org: User:
Start: 11/05/19 End: 08/15/22 Due: 08/15/23

Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01197287 Org: User:
Start: 05/31/04 End: - Due: -

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

Phase: N/A Priority: Normal
NCT ID: NCT01155700 Org: User:
Start: 06/30/10 End: 02/29/12 Due: 02/28/13

A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00171860 Org: User:
Start: 09/30/02 End: - Due: -

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Phase: N/A Priority: Normal
NCT ID: NCT01900782 Org: User:
Start: 10/31/13 End: 06/30/15 Due: 06/30/16

Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00688909 Org: User:
Start: 03/31/08 End: 06/30/09 Due: 06/30/10

Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00372476 Org: User:
Start: 06/30/06 End: 07/31/12 Due: 07/31/13

Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00136851 Org: User:
Start: 12/31/04 End: 07/31/05 Due: 07/31/06

Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.

Phase: N/A Priority: Normal
NCT ID: NCT02732119 Org: User:
Start: 06/14/16 End: 02/25/20 Due: 02/25/21

Long-term Study of Ciclosporin for Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00232063 Org: User:
Start: 05/31/04 End: - Due: -

An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00171730 Org: User:
Start: 08/24/04 End: 12/06/13 Due: 12/06/14

Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib

Phase: N/A Priority: Normal
NCT ID: NCT00471328 Org: User:
Start: 03/31/07 End: 06/30/11 Due: 06/30/12

Lamprene Multiple Patient Program

Phase: N/A Priority: Normal
NCT ID: NCT04334070 Org: User:
Start: - End: - Due: -

Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01430416 Org: User:
Start: 12/20/11 End: 05/22/19 Due: 05/22/20